Reinilde Heyrman
Overview
Reinilde Heyrman received an average of $642K in total compensation, including $350K in salary, at Bellerophon Therapeutics between 2014 and 2015.
Source: SEC filing on April 27, 2016.
Related executives
We found seven more executives who work or worked at Bellerophon Therapeutics.
Fabian Tenenbaum
Bellerophon Therapeutics
Chief Executive Officer
Peter Fernandes
Bellerophon Therapeutics
Chief Regulatory and Safety Officer
Assaf Korner
Bellerophon Therapeutics
Chief Financial Officer
Deborah Quinn
Bellerophon Therapeutics
Chief Medical Officer
Jonathan Peacock
Bellerophon Therapeutics
Chief Executive Officer
Martin Meglasson
Bellerophon Therapeutics
Chief Scientific Officer
Martin Dekker
Bellerophon Therapeutics